or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    GILD A 0.78 5.61
    BGNE C 0.77 5.52
    EXEL A 2.77 5.20
    RVMD A 2.97 4.70
    INCY A 2.71 4.49
    SRPT D -2.15 4.34
    ACLX B 2.25 3.85
    REGN F 0.64 3.80
    MRK F -0.43 3.25
    IOVA B 7.18 2.72
    TWST F 3.00 2.58
    GERN C 0.00 2.32
    LGND A 4.11 2.24
    SWTX D 1.63 2.20
    BEAM F 4.66 1.89
    BCRX A 5.24 1.80
    NRIX B -0.45 1.70
    DVAX A -0.59 1.59
    NVAX F -2.71 1.48
    MRNA F 0.50 1.43
    BPMC C 3.65 1.29
    CRSP C 9.42 0.98
    IBRX B 1.34 0.94
    RCUS F 1.31 0.89
    VIR B 23.63 0.76
    ARCT F 1.52 0.53
    OABI D 2.20 0.41
    FDMT F 1.06 0.40
    NTLA F 4.15 0.39
    QURE B 2.45 0.36
    DNA D 1.71 0.33
    XNCR A 1.19 0.32
    EDIT F 0.34 0.30
    MGNX C 5.74 0.23

    Represented by ETF Holdings

    Keywords: Biotechnology Biopharmaceutical Cancer Medicine Biology Life Sciences Immune System Infectious Diseases Monoclonal Antibodies Antibodies Clinical Development Clinical Medicine Coronavirus Genetics Immunology Influenza S&P 500 Cancer Treatment Enzymes Nasdaq 100
    Industries: Biotechnology Drug Manufacturers - Major Diagnostics & Research

    Recent News for iShares Genomics Immunology and Healthcare ETF & its Holdings

    Date Stock Title
    Nov 2 VIR Vir Biotechnology Third Quarter 2024 Earnings: Misses Expectations
    Nov 2 INCY What Moved Markets This Week
    Nov 1 DVAX Bath & Body Works, Paramount Global, and More Stocks See Action From Activist Investors
    Nov 1 VIR Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ...
    Nov 1 MRK Merck's Gardasil Shot Challenges To Continue, Analysts Optimistic For Newly Approved Sotatercept For Rare Lung Disease
    Nov 1 VIR Vir Biotechnology Q3 2024 Earnings Preview
    Nov 1 BCRX BioCryst Pharmaceuticals Q3 2024 Earnings Preview
    Nov 1 MGNX Discover Alpha Tau Medical And 2 Other US Penny Stocks
    Nov 1 GILD Stocks to watch next week: Berkshire Hathaway, Super Micro, Novo Nordisk, Vistry and M&S
    Nov 1 BPMC High Growth Tech Stocks to Watch in November 2024
    Nov 1 VIR Vir Biotechnology (NASDAQ:VIR) shareholders have endured a 76% loss from investing in the stock three years ago
    Nov 1 XNCR Does Xencor (XNCR) Have the Potential to Rally 68.16% as Wall Street Analysts Expect?
    Nov 1 BPMC Blueprint Medicines Third Quarter 2024 Earnings: EPS Beats Expectations
    Nov 1 GILD Ahead of Gilead (GILD) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
    Nov 1 REGN What Makes Regeneron Pharmaceuticals (REGN) an Attractive Investment Opportunity?
    Nov 1 LGND Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston
    Nov 1 MRK Merck Third Quarter 2024 Earnings: EPS Misses Expectations
    Nov 1 REGN Regeneron Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
    Nov 1 EXEL Exelixis, Inc. Just Recorded A 18% EPS Beat: Here's What Analysts Are Forecasting Next
    Nov 1 REGN Regeneron: Investors In Panic Mode On Increased Eylea Fears
    The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
    Exchange Traded Fund Immunology Genomics
    Back to the Main IDNA Page...